Unosource Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 18.02 Cr
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.00 Cr
- Satisfied Charges ₹ 7.00 Cr
- Revenue Growth 34.87%
- Profit Growth 43.49%
- Ebitda 16.78%
- Net Worth 33.57%
- Total Assets 56.67%
About Unosource Pharma
Unosource Pharma Limited (UPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 December 2013 and has a history of 11 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 18.02 Cr.
The company currently has active open charges totaling ₹50.00 Cr. The company has closed loans amounting to ₹7.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Unosource Pharma Limited India are Eti Vashist as Company Secretary, Ashok Saroha as Ceo, and Sumeet Sood as Cfo. Sanjay Chalke, Rama Shanker, Manju Bist, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233DL2013PLC262364
- Company No.
262364
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2013
- Date of AGM
29 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Unosource Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumeet Sood  | CFO | 10-Jun-2022 | Current |
| Eti Vashist | Company Secretary | 01-Sep-2020 | Current |
| Ashok Saroha | CEO | 27-May-2023 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Chalke | Director | 13-Jan-2017 | Current |
| Rama Shanker | Director | 07-Jun-2024 | Current |
| Manju Bist | Additional Director | 27-Aug-2024 | Current |
| Manmohan Singh | Director | 15-Jun-2015 | Current |
Financial Performance of Unosource Pharma.
Unosource Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.87% increase. The company also saw a substantial improvement in profitability, with a 43.49% increase in profit. The company's net worth Soared by an impressive increase of 33.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unosource Pharma?
In 2023, Unosource Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akumentis Healthcare LimitedSanjay Chalke and Manmohan Singh are mutual person
Akums Drugs And Pharmaceuticals LimitedSumeet Sood is a mutual person
- Pure And Cure Healthcare Private Limited
Rama Shanker is a mutual person
- Malik Lifesciences Private Limited
Manmohan Singh is a mutual person
Amazing Research Laboratories LimitedRama Shanker is a mutual person
Akums Healthcare LimitedRama Shanker is a mutual person
Charges (Loans)
₹50.00 Cr
₹7.00 Cr
Charges Breakdown by Lending Institutions
- The Hongkong And Shanghai Banking Corporation Limited : 25.00 Cr
- Citi Bank N.A. : 20.00 Cr
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2023 | Others | ₹5.00 Cr | Open |
| 14 Jul 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹25.00 Cr | Open |
| 16 Dec 2022 | Citi Bank N.A. | ₹20.00 Cr | Open |
| 02 Apr 2018 | Yes Bank Limited | ₹5.00 Cr | Satisfied |
| 28 May 2015 | Yes Bank Limited | ₹2.00 Cr | Satisfied |
How Many Employees Work at Unosource Pharma?
Unosource Pharma has a workforce of 41 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unosource Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unosource Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
